GU Cancers 2019 | Concordance of different PD-L1 assays: expression in bladder and kidney cancer

Tian Zhang

Tian Zhang, MD, of Duke Cancer Center, Durham, NC, discusses work being presented at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA, on the comparability of different PD-L1 assays for both bladder and kidney cancer.

Share this video